查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520592

2024-2032年按皮膚疾病、給藥途徑、配銷通路及地區分類的皮膚科藥物市場

Dermatological Drugs Market by Dermatological Diseases, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球皮膚科藥物市場規模達238億美元。皮膚病患病率的上升、對藥妝品的需求不斷增加以及個人對皮膚健康意識的不斷增強是推動市場發展的一些關鍵因素。

皮膚科藥物是用於治療各種皮膚病的藥物，包括痤瘡、牛皮癬、濕疹、紅斑性痤瘡、皮膚癌、真菌感染以及其他影響皮膚、頭髮和指甲的疾病。這些藥物可以局部、口服或注射使用，這取決於所治療的皮膚病的類型。外用皮膚科藥物，包括乳膏、軟膏、凝膠和噴霧劑，直接塗在皮膚上。它們最常用於治療局部皮膚病，例如痤瘡或濕疹。另一方面，全身性皮膚病藥物是透過口服或注射的方式服用，並透過針對皮膚狀況的根本原因發揮作用。這些藥物通常用於治療嚴重或廣泛的皮膚病，例如牛皮癬。這些產品具有化妝品和藥物特性，旨在改善皮膚的整體健康和外觀。此外，皮膚科藥物是由皮膚科醫生或其他具有皮膚健康專業知識的醫療保健專業人員開出的，這使得全球範圍內的需求不斷增加。

皮膚科藥物市場趨勢：

該市場的主要推動力是牛皮癬、濕疹、痤瘡、紅斑痤瘡和皮膚癌等皮膚病的日益流行。此外，越來越多的老年人口更容易患此類疾病，這是另一個主要的生長誘導因素。除此之外，人們廣泛採用藥妝品，它們是具有藥物特性的化妝品，可改善皮膚的整體健康和外觀。再加上人們對維持皮膚健康重要性的認知不斷增強，正在對市場成長產生正面影響。現在，患者更加意識到尋求皮膚病治療，導致皮膚科藥物的整體需求增加。此外，藥物傳遞系統的各種技術進步，如經皮貼片、奈米技術和微針，正在推動皮膚科藥物市場的成長。這些新的藥物輸送系統提高了藥物的功效並提高了患者的依從性。此外，消費者可支配收入的增加、非處方藥（OTC）的日益普及以及對可用治療方案的認知不斷提高是在全球範圍內創造良好市場前景的其他一些因素。

本報告回答的關鍵問題：

  • 迄今為止，全球皮膚科藥物市場表現如何，未來幾年將如何表現？
  • 全球皮膚科藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球皮膚科藥物市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的皮膚科藥物市場？
  • 基於皮膚病的市場區隔是什麼？
  • 皮膚科用藥市場上最吸引人的皮膚科疾病是什麼？
  • 根據給藥途徑，市場的分化為何？
  • 皮膚科藥物市場上哪種給藥途徑最具吸引力？
  • 基於配銷通路的市場區隔是什麼？
  • 皮膚科藥品市場最具吸引力的配銷通路是哪一個？
  • 全球皮膚科用藥市場競爭格局如何？
  • 全球皮膚科藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球皮膚科藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場細分：依皮膚病分類

  • 粉刺
    • 市場走向
    • 市場預測
  • 皮膚炎
    • 市場走向
    • 市場預測
  • 牛皮癬
    • 市場走向
    • 市場預測
  • 皮膚癌
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依管理途徑

  • 口服
    • 市場走向
    • 市場預測
  • 注射用
    • 市場走向
    • 市場預測
  • 專題
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Bausch Health Companies Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GSK plc
    • LEO Pharma A/S (LEO Holding A/S)
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112024A7758

The global dermatological drugs market size reached US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 53.3 Billion by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.

Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.

Dermatological Drugs Market Trends:

The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dermatological drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on dermatological diseases, route of administration, and distribution channel.

Dermatological Diseases Insights:

Dermatological Drugs Market

Acne

Dermatitis

Psoriasis

Skin Cancer

Others

The report has provided a detailed breakup and analysis of the dermatological drugs market based on the dermatological diseases. This includes acne, dermatitis, psoriasis, skin cancer, and others. According to the report, psoriasis represented the largest segment.

Route of Administration Insights:

Oral

Parenteral

Topical

A detailed breakup and analysis of the dermatological drugs market based on the route of administration has also been provided in the report. This includes oral, parenteral, and topical. According to the report, parenteral accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has provided a detailed breakup and analysis of the dermatological drugs market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global dermatological drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global dermatological drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global dermatological drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive dermatological drugs market?
  • What is the breakup of the market based on dermatological diseases?
  • Which is the most attractive dermatological disease in the dermatological drugs market?
  • What is the breakup of the market based on the route of administration?
  • Which is the most attractive route of administration in the dermatological drugs market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the dermatological drugs market?
  • What is the competitive structure of the global dermatological drugs market?
  • Who are the key players/companies in the global dermatological drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dermatological Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dermatological Diseases

  • 6.1 Acne
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dermatitis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Psoriasis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Skin Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bausch Health Companies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 LEO Pharma A/S (LEO Holding A/S)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Dermatological Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Dermatological Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Dermatological Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Dermatological Drugs Market: Breakup by Dermatological Diseases (in %), 2023
  • Figure 5: Global: Dermatological Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Dermatological Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Dermatological Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Dermatological Drugs (Acne) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Dermatological Drugs (Acne) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Dermatological Drugs (Dermatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Dermatological Drugs (Dermatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Dermatological Drugs (Psoriasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Dermatological Drugs (Psoriasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Dermatological Drugs (Skin Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Dermatological Drugs (Skin Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Dermatological Drugs (Other Dermatological Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Dermatological Drugs (Other Dermatological Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Dermatological Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Dermatological Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Dermatological Drugs (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Dermatological Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Dermatological Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Dermatological Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Dermatological Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Dermatological Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Dermatological Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Dermatological Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Dermatological Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Dermatological Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Dermatological Drugs Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Dermatological Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: Dermatological Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Dermatological Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dermatological Drugs Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Dermatological Drugs Market Forecast: Breakup by Dermatological Diseases (in Million US$), 2024-2032
  • Table 3: Global: Dermatological Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Dermatological Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Dermatological Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Dermatological Drugs Market: Competitive Structure
  • Table 7: Global: Dermatological Drugs Market: Key Players